Practitioners Mostly Agree Amgen Won’t Be a Sea Change, But Some Predict Grim Consequences
March 28, 2023
Eileen McDermott
IPWatchdog
Axinn counsel Thomas Hedemann and associate Patrick Doyle were quoted in the IPWatchdog article, "Practitioners Mostly Agree Amgen Won’t Be a Sea Change, But Some Predict Grim Consequences."
Click here to access the article.